Anna Maria Cernigoi

Acute-Phase Markers of Inflammation and Glomerular Structure in Patients with Type 2 Diabetes

Michele Dalla Vestra, Michele Mussap, Pietro Gallina et al. · Journal of the American Society of Nephrology · 2005 · 302 citations · Full text

Long-term (23 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients

Mario Velussi, Anna Maria Cernigoi, De Monte Ariella et al. · Journal of Hepatology · 1997 · 213 citations

Metabolic Syndrome, Diabetes Management, Anti-oxidant Drug +10

The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events

F Mindlen, Roberto Nordaby, M I Soto Ruiz et al. · Queensland's institutional digital repository (The University of Queensland) · 1996 · 154 citations

Non-pharmacological Intervention, Preventive Medicine, Cardiovascular Disease +10

Effects of Cilazapril and Amlodipine on Kidney Function in Hypertensive NIDDM Patients

Mario Velussi, Enrico Brocco, Francesco Frigato et al. · Diabetes · 1996 · 150 citations

Type I Diabetes is Characterized by Insulin Resistance Not Only with Regard to Glucose, but also to Lipid and Aminoacid Metabolism*

Roberto Trevisan, R. Nosadini, Angelo Avogaro et al. · The Journal of Clinical Endocrinology & Metabolism · 1986 · 51 citations